Cargando…
Evaluation of biomarkers for doxorubicin‑induced cardiac injury in rats
Drug-induced cardiotoxicity is a leading cause of failure in drug development and predicting its occurrence in non-clinical studies is the primary preventive measure. The present study aimed to evaluate the changes in biomarkers during acute and chronic myocardial injury induced by doxorubicin (DOX)...
Autores principales: | Pan, Dong-Sheng, Li, Bo, Wang, San-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634690/ https://www.ncbi.nlm.nih.gov/pubmed/36349063 http://dx.doi.org/10.3892/etm.2022.11648 |
Ejemplares similares
-
Tetrandrine Attenuated Doxorubicin-Induced Acute Cardiac Injury in Mice
por: Li, Gang, et al.
Publicado: (2020) -
Antiresistin Neutralizing Antibody Alleviates Doxorubicin-Induced Cardiac Injury in Mice
por: Hu, Yewen, et al.
Publicado: (2022) -
Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response
por: Hadi, Najah, et al.
Publicado: (2012) -
Cardioprotective Effect of Quercetin and Sitagliptin in Doxorubicin-Induced Cardiac Toxicity in Rats
por: Aziz, Tavga Ahmed
Publicado: (2021) -
Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020)